What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Pathology
The scientist’s investigation covers issues in Pathology, Surgery, Glioma, Radiation therapy and Biopsy.
His Pathology research includes elements of Fluorescence in situ hybridization, Central nervous system disease and Anatomy.
His Surgery research includes themes of Pituitary adenoma, Adenoma and Transsphenoidal surgery.
His studies deal with areas such as Endocrinology, Pituitary tumors, Acromegaly, Pituitary neoplasm and Adrenocorticotropic hormone as well as Adenoma.
His study looks at the relationship between Radiation therapy and topics such as Survival rate, which overlap with Chemotherapy.
Bernd W. Scheithauer works mostly in the field of Biopsy, limiting it down to topics relating to Magnetic resonance imaging and, in certain cases, Nuclear medicine.
His most cited work include:
- Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. (2596 citations)
- The new WHO classification of brain tumours. (1276 citations)
- Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. (1188 citations)
What are the main themes of his work throughout his whole career to date?
Bernd W. Scheithauer mostly deals with Pathology, Internal medicine, Immunohistochemistry, Endocrinology and Surgery.
His Pathology research incorporates themes from Astrocytoma, Glioma and Anatomy.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology.
His research links Meningioma with Immunohistochemistry.
His studies in Radiation therapy and Central nervous system disease are all subfields of Surgery research.
His work deals with themes such as Pituitary neoplasm and Pituitary tumors, which intersect with Adenoma.
He most often published in these fields:
- Pathology (62.44%)
- Internal medicine (24.49%)
- Immunohistochemistry (15.90%)
What were the highlights of his more recent work (between 2009-2015)?
- Pathology (62.44%)
- Internal medicine (24.49%)
- Pituitary adenoma (11.92%)
In recent papers he was focusing on the following fields of study:
Bernd W. Scheithauer mainly focuses on Pathology, Internal medicine, Pituitary adenoma, Immunohistochemistry and Endocrinology.
His Pathology study combines topics from a wide range of disciplines, such as Pituitary neoplasm, Astrocytoma and Anatomy.
His Pituitary neoplasm study incorporates themes from Cancer research and Adrenocorticotropic hormone.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology.
The Pituitary adenoma study combines topics in areas such as Corticotropic cell, Pituitary carcinoma, Endoglin and Temozolomide.
His Immunohistochemistry research is multidisciplinary, incorporating perspectives in Blood flow, Metastasis, Glomus tumor and Histology.
Between 2009 and 2015, his most popular works were:
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis (689 citations)
- Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. (186 citations)
- Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. (129 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Bernd W. Scheithauer focuses on Pathology, Pituitary adenoma, Internal medicine, Pituitary tumors and Cancer research.
His Pathology research integrates issues from Cancer and In situ hybridization.
He has included themes like Corticotropic cell, Pituitary gland, Proliferation index, Hydrocephalus and Chromogranin A in his Pituitary adenoma study.
The various areas that Bernd W. Scheithauer examines in his Internal medicine study include Gastroenterology, Endocrinology and Oncology.
The study incorporates disciplines such as Pituitary neoplasm, Pituitary carcinoma and Temozolomide in addition to Pituitary tumors.
His study looks at the intersection of Biopsy and topics like Anaplasia with Astrocytoma and Glioma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
